Walleye Capital’s Myriad Genetics MYGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $241K | Sell |
45,472
-141,130
| -76% | -$749K | ﹤0.01% | 1316 |
|
|
2025
Q1 | $1.66M | Buy |
+186,602
| New | +$1.66M | 0.01% | 656 |
|
|
2024
Q1 | – | Sell |
-17,228
| Closed | -$330K | – | 2867 |
|
|
2023
Q4 | $330K | Buy |
17,228
+16,907
| +5,267% | +$324K | ﹤0.01% | 1322 |
|
|
2023
Q3 | $5.15K | Buy |
+321
| New | +$5.15K | ﹤0.01% | 2015 |
|
|
2023
Q2 | – | Sell |
-26,149
| Closed | -$607K | – | 2575 |
|
|
2023
Q1 | $607K | Sell |
26,149
-12,977
| -33% | -$301K | 0.01% | 923 |
|
|
2022
Q4 | $568K | Buy |
39,126
+17,880
| +84% | +$259K | 0.01% | 943 |
|
|
2022
Q3 | $405K | Buy |
+21,246
| New | +$405K | 0.01% | 1143 |
|
|
2022
Q2 | – | Sell |
-15,852
| Closed | -$399K | – | 2534 |
|
|
2022
Q1 | $399K | Buy |
+15,852
| New | +$399K | 0.01% | 1090 |
|
|
2021
Q4 | – | Sell |
-7,381
| Closed | -$238 | – | 2178 |
|
|
2021
Q3 | $238 | Buy |
+7,381
| New | +$238 | 0.01% | 1103 |
|
|
2020
Q4 | – | Sell |
-46,114
| Closed | -$601K | – | 1038 |
|
|
2020
Q3 | $601K | Buy |
46,114
+24,288
| +111% | +$317K | 0.07% | 323 |
|
|
2020
Q2 | $248K | Sell |
21,826
-3,154
| -13% | -$35.8K | 0.06% | 375 |
|
|
2020
Q1 | $358K | Buy |
24,980
+24,722
| +9,582% | +$354K | 0.08% | 209 |
|
|
2019
Q4 | $7K | Buy |
258
+158
| +158% | +$4.29K | ﹤0.01% | 601 |
|
|
2019
Q3 | $3K | Buy |
+100
| New | +$3K | ﹤0.01% | 460 |
|
|
2019
Q2 | – | Sell |
-300
| Closed | -$10K | – | 754 |
|
|
2019
Q1 | $10K | Buy |
+300
| New | +$10K | ﹤0.01% | 328 |
|